Sanatan Saraf
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Surgery top 5%
- Immunology top 5%
- Molecular Biology
- Co-authors
- Sarina A. Piha‐PaulPatrick A. OttEmilie M.J. van BrummelenAnne MoroskyBilal PiperdiÉlena ElezChristophe Le TourneauHope S. Rugo
- Topics
- Cancer Immunotherapy and Biomarkers (34 papers)Lung Cancer Treatments and Mutations (13 papers)Lung Cancer Diagnosis and Treatment (6 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- United StatesFranceTaiwan
In The Last Decade
Sanatan Saraf
42 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 3.3k
- Pulmonary and Respiratory Medicine 1.5k
- Surgery 977
- Immunology 800
- Molecular Biology 451
Countries citing papers authored by Sanatan Saraf
This map shows the geographic impact of Sanatan Saraf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanatan Saraf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanatan Saraf more than expected).
Fields of papers citing papers by Sanatan Saraf
This network shows the impact of papers produced by Sanatan Saraf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanatan Saraf. The network helps show where Sanatan Saraf may publish in the future.
Co-authorship network of co-authors of Sanatan Saraf
This figure shows the co-authorship network connecting the top 25 collaborators of Sanatan Saraf. A scholar is included among the top collaborators of Sanatan Saraf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanatan Saraf. Sanatan Saraf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 148 | |
| 5 | 25 | |
| 6 | 169 | |
| 7 | 130 | |
| 8 | 68 | |
| 9 | 74 | |
| 10 | Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Studybreakdown → | 377 |
| 11 | Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trialbreakdown → | 386 |
| 12 | 10 | |
| 13 | 259 | |
| 14 | 164 | |
| 15 | Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trialbreakdown → | 325 |
| 16 | 19 | |
| 17 | 3 | |
| 18 | 36 | |
| 19 | 13 | |
| 20 | 1 |
About Sanatan Saraf
Sanatan Saraf is a scholar working on Oncology, Otorhinolaryngology and Obstetrics and Gynecology, having authored 43 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (34 papers), Lung Cancer Treatments and Mutations (13 papers) and Lung Cancer Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (3.3k citations), Otorhinolaryngology (213 citations) and Obstetrics and Gynecology (363 citations). Sanatan Saraf has collaborated with scholars based in United States, France and Taiwan. Frequent co-authors include Sarina A. Piha‐Paul, Patrick A. Ott, Emilie M.J. van Brummelen, Anne Morosky, Bilal Piperdi, Élena Elez, Christophe Le Tourneau, Hope S. Rugo, Juanita Lopez and Andréa Varga. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.